Company / Accounts Receivable
Evolus, Inc. Accounts Receivable History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$54.7M
FY2025
5-year range
$14.7M / $54.7M
FY2021-FY2025
Trend
+14.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable has increased for 5 consecutive years, from $10M in FY2020 to $55M in FY2025.
Based on SEC 10-K filings.
$55M in FY2025 with a 5-year CAGR of +41.4%.
Improved from $31M to $55M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +34.6%
- 5-Year CAGR
- +41.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- Evolus, Inc.'s accounts receivable has grown for 5 consecutive years.
- 5-year CAGR of +41.4%, indicating consistent growth.
- In FY2025, accounts receivable increased 14.7% year-over-year.
- Lowest accounts receivable in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $54.7M | +14.7% |
| FY2024 | $47.7M | +56.2% |
| FY2023 | $30.5M | +36.0% |
| FY2022 | $22.4M | +53.2% |
| FY2021 | $14.7M | +51.4% |
| FY2020 | $9.7M | -9.2% |
| FY2019 | $10.7M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026